RhoVac

News

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase 2b trial of its prostate

News

SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.